05 March 2025
MaxRets Ventures PLC
("MaxRets" or the "Company")
Result of General Meeting
MaxRets Ventures plc (AQSE: MAX), an investing company focusing on early-stage growth or undervalued later stage businesses with strong upside potential, announces that at the General Meeting held yesterday, all resolutions were duly passed.
As such, the withdrawal of the Company's ordinary shares of 1p each ("Ordinary Shares") from trading on the Access Segment of the Growth Market of the Aquis Stock Exchange ("AQSE Growth Market") (the "Withdrawal") will take effect at 8:00 a.m. on 18 March 2025.
Subsequently, as noted in the Circular, MaxRets will re-register as a private company (the "Re-Registration") and adopt new articles of association (the "New Articles") which is expected to take place on 11 April 2025.
The timetable from the Circular has been appended below and the full Circular can be found on the Company's website https://maxrets.com/ .
Expected Timetable of Principle Events
| |
2025 |
| |
|
| Publication and posting of the Circular |
14 February |
| |
|
| Latest time for receipt of proxy appointments in respect of the General Meeting |
11.00 a.m. on 28 February |
| |
|
| General Meeting |
11.00 a.m. on 4 March |
| |
|
| Last day of dealings in Ordinary Shares on the Growth Market of the Aquis Stock Exchange |
17 March |
| |
|
| Proposed Withdrawal |
8.00 a.m. on 18 March |
| |
|
| Expected re-registration as a private company |
by 11 April |
The Directors of the Company are responsible for the content of this announcement.
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales.
For further information please contact:
Enquiries:
| MaxRets Ventures plc Luciano Maranzana, Non-Executive Director
|
|
|
Cairn Financial Advisers LLP AQSE Corporate Adviser Jo Turner / Liam Murray / Ed Downes
|
+44 20 7213 0880 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.